CANNASSURE THERAPEUTICS LTD Inactive Instrument
Cannassure Therapeutics Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
| Sales 2022 | 33.78 125.38 2.69K | Sales 2023 | 11 40.82 876.1 | Capitalization | 4M 14.85M 319M |
|---|---|---|---|---|---|
| Net income 2022 | -5M -18.56M -398M | Net income 2023 | -1M -3.71M -79.66M | EV / Sales 2022 | 1,023,292 x |
| Net Debt 2022 | 29.96M 111M 2.39B | Net Debt 2023 | 2.43M 9.03M 194M | EV / Sales 2023 | 585,038 x |
| P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 101.78% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 30/03/22 |
Nir Peles
CHM | Chairman | 51 | 03/12/18 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 25/06/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 03/12/18 |
Nir Peles
CHM | Chairman | 51 | 03/12/18 |
Varda Kalal
BRD | Director/Board Member | 56 | 13/02/22 |
Cannassure Therapeutics Ltd, formerly Direct Capital Investments Ltd, is an Israel-based real estate company. The Company has two main business activities; Yielding real estate and real estate investments in which the Company, directly and through its subsidiaries; locates, purchases, rents, upgrades and manages real estate. The Company and its subsidiaries have investments and property rights in Germany, Serbia, India, Kazakhstan, Latvia and Israel.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 339M | |
| +35.05% | 279M | |
| +36.21% | 266M | |
| +45.93% | 190M | |
| +156.53% | 145M | |
| -35.62% | 133M | |
| +43.74% | 130M | |
| +15.38% | 100M | |
| -42.86% | 96.7M |
